Retrospective Study
Copyright ©The Author(s) 2022.
World J Gastrointest Surg. Dec 27, 2022; 14(12): 1350-1362
Published online Dec 27, 2022. doi: 10.4240/wjgs.v14.i12.1350
Table 3 Univariate and multivariate analysis of risk factors for recurrence-free survival following pancreatic cancer resection
FactorUnivariate analysis
P valueMultivariate analysis
P value
HR (95%CI)
HR (95%CI)
Age > 65 yr1.661 (0.905-3.051)0.102
Male sex0.631 (0.382-1.041)0.071
BMI < 20.0 underweight1.216 (0.660-2.240)0.530
BMI ≥ 25.0 obesity1.823 (0.969-3.430)0.062
Albumin < 3.8 g/dL0.871 (0455-1.668)0.677
Low SMI1.784 (1.083-2.939)0.023a1.907 (1.147-3.171)0.013a
Low SMD1.567 (0.885-2.773)0.123
Tumor location, head1.327 (0.795-2.215)0.278
Tumor size > 2 cm1.611 (0.767-3.382)0.208
Differentiation poor0.978 (0.238-4.022)0.976
Nodal metastases1.897 (1.134-3.174)0.015a1.922 (1.129-3.272)0.016a
Perineural invasion1.886 (0.841-4.231)0.124
R1 Resection1.593 (0.754-3.365)0.222
TNM stage III1.703 (0.833-3.483)0.144
Adjuvant therapy0.866 (0.479-1.567)0.635
CA19-9 in Ku/L > 2001.439 (0.855-2.421)0.170
NLR > 2.61.071 (0.648-1.769)0.789
PLR > 1081.612 (0.955-2.722)0.074
SIII > 4001.827 (1.097-3.043)0.021a1.655 (0.984-2.785)0.058
Platelets > 310 × 1091.245 (0.533-2.910)0.613